Partial
Mostly Aligned
Patient Risk:
Low
Summary
The claims largely reflect approved pediatric use (UTI, AOM), composition, mechanism, and safety warnings for Sulfatrim. A notable discrepancy is a mischaracterization of use in infants (kernicterus risk) and an off-label pneumonia claim. Several non-label items (adult indications, patents/generic status, and specific dosing details) are not supported by the provided label excerpt.
Category Scores
Accurate Statements
Sulfatrim pediatric suspension is a prescription medication.
Rx only (Sulfamethoxazole and Trimethoprim Oral Suspension)
It contains trimethoprim and sulfamethoxazole.
Sulfatrim - sulfamethoxazole and trimethoprim suspension
It is used to treat bacterial infections in children.
INDICATIONS AND USAGE; Pediatric use
It is available in a liquid suspension form.
HOW SUPPLIED; Oral Suspension
It is prescribed for urinary tract infections in children.
Urinary Tract Infections
It is prescribed for ear infections (otitis media) in children.
Acute Otitis Media
It is prescribed for a variety of bacterial infections in children.
INDICATIONS AND USAGE; general susceptible bacteria
It is effective against a range of bacteria that commonly cause these infections.
Microbiology; lists susceptible organisms and in vitro activity
The active ingredients trimethoprim and sulfamethoxazole work together to inhibit the growth of bacteria.
Microbiology; mechanism of action
Sulfatrim is a combination drug of trimethoprim and sulfamethoxazole.
Sulfatrim - sulfamethoxazole and trimethoprim suspension
Other sulfa drugs contain only a single sulfonamide component.
Information for Patients
The combination in Sulfatrim provides a synergistic effect.
Microbiology
This makes it more effective against certain infections than single-agent sulfonamides.
Microbiology
Patients should be aware of potential allergic reactions.
Information for Patients; Hypersensitivity
Sulfatrim can interact with other medications.
Drug Interactions
A complete list of all medications the child is taking should be provided to the doctor.
Drug Interactions
It should be used with caution in infants under two months of age due to the risk of kernicterus.
Pediatric use (not supported as a caution; label states not recommended for <2 months)
Sulfatrim is a combination drug of trimethoprim and sulfamethoxazole.
Sulfatrim - sulfamethoxazole and trimethoprim suspension
Trimethoprim/sulfamethoxazole is used to treat bacterial infections in adults.
Absent from INDICATIONS AND USAGE for pediatric label (adult indication not listed in provided extract)
It is often in tablet form in adults.
Absent from provided label excerpt
The dosage may differ from pediatric use.
Absent from provided label excerpt
The indications may differ from pediatric use.
Absent from provided label excerpt
Unsupported Statements
It is prescribed for certain types of pneumonia in children.
Not listed as an approved indication in Indications and Usage; pneumonia not specified in provided pediatric label.
Patients with a history of sulfa allergies are especially at risk for allergic reactions.
Label mentions hypersensitivity but does not explicitly state increased risk for patients with sulfa allergies.
Original patents for trimethoprim/sulfamethoxazole expired many years ago.
Patents not discussed in the provided label excerpt.
Generic versions are produced.
Not described in the provided label excerpt.
Several other antibiotics can be used to treat bacterial infections in children. These may include amoxicillin, cephalexin, azithromycin.
Not listed as alternatives within Indications and Usage; not supported by label excerpt.
A healthcare provider will select the most appropriate antibiotic based on the diagnosed infection and potential drug resistance.
While the label notes considering culture/susceptibility data, the exact phrasing 'will select the most appropriate antibiotic' is not directly quoted from the label; considered aligned but treated as partially supported.
Crystalluria and Stone Formation
This is presented in the label under Information for Patients; not an unsupported statement but not a standalone factual claim outside the label sections.
Kernicterus risk in infants under two months requires caution rather than not recommended.
Label states Not recommended for infants younger than 2 months; the claim contradicts the label guidance.
Trimethoprim/sulfamethoxazole is used to treat bacterial infections in adults.
Not supported by the provided label excerpt (adult indication not included).
It is often in tablet form in adults.
Not described in the provided label excerpt.
The dosage may differ from pediatric use.
Not described in the provided label excerpt.
The indications may differ from pediatric use.
Not described in the provided label excerpt.
Contradictions
High
AI Statement
It should be used with caution in infants under two months of age due to the risk of kernicterus.
Label Reference
INDICATIONS AND USAGE; Pediatric use
Important Omissions
Dosing details for pediatric patients (weight-based dosing or age-based dosing ranges) are not provided in the extracted label excerpts.
Importance:
High
Explicit contraindications (e.g., hypersensitivity to sulfonamides) are not delineated in the claims; the label contains Contraindications not captured by the claims.
Importance:
High
Safety Assessment
Potential Patient Risk:
Low
The claims align with common safety themes (hypersensitivity, interactions, not approved <2 months) with some acknowledged severe risks in the label; one incorrect assertion increases risk of unsafe interpretation.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Incorrect statement about kernicterus risk leading to 'caution' in infants <2 months; not recommended is the correct label guidance.
Suggested Improvement
Replace infant dosing/contraindication language with 'Not recommended for infants younger than 2 months due to risk of kernicterus'; identify pneumonia as off-label (not approved) in the Indications/Usage; consider including explicit adult indications if applicable; include precise weight-based pediatric dosing guidance if provided in the full label.